Zülfikar, O. B. Et Al. 2024. Long-Term Outcomes with Efanesoctocog Alfa Prophylaxis for Previously Treated Children With Severe Hemophilia A, an Interim Analysis of the Phase 3 XTEND-ed Study.. ISTH , (Bangkok, Thailand), 1.

Zülfikar, O. B., Malec, ., Nolan , B., Anthony Kc, K., Albisetti M, , M., Chou Sc,, S., ... Simpson M, , M.(2024). Long-Term Outcomes with Efanesoctocog Alfa Prophylaxis for Previously Treated Children With Severe Hemophilia A, an Interim Analysis of the Phase 3 XTEND-ed Study. . ISTH (pp.1). Bangkok, Thailand

Zülfikar, Osman Et Al. "Long-Term Outcomes with Efanesoctocog Alfa Prophylaxis for Previously Treated Children With Severe Hemophilia A, an Interim Analysis of the Phase 3 XTEND-ed Study.," ISTH, Bangkok, Thailand, 2024

Zülfikar, Osman B. Et Al. "Long-Term Outcomes with Efanesoctocog Alfa Prophylaxis for Previously Treated Children With Severe Hemophilia A, an Interim Analysis of the Phase 3 XTEND-ed Study.." ISTH , Bangkok, Thailand, pp.1, 2024

Zülfikar, O. B. Et Al. (2024) . "Long-Term Outcomes with Efanesoctocog Alfa Prophylaxis for Previously Treated Children With Severe Hemophilia A, an Interim Analysis of the Phase 3 XTEND-ed Study.." ISTH , Bangkok, Thailand, p.1.

@conferencepaper{conferencepaper, author={Osman Bülent ZÜLFİKAR Et Al. }, title={Long-Term Outcomes with Efanesoctocog Alfa Prophylaxis for Previously Treated Children With Severe Hemophilia A, an Interim Analysis of the Phase 3 XTEND-ed Study.}, congress name={ISTH}, city={Bangkok}, country={Thailand}, year={2024}, pages={1} }